| http://purl.uniprot.org/citations/18923545 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/18923545 | http://www.w3.org/2000/01/rdf-schema#comment | "Multiple sclerosis is a complex human neurodegenerative disease, characterized by the active destruction of the insulating myelin sheath around the axons in the central nervous system. The physical deterioration of myelin is mediated by hyperdeimination of myelin basic and other proteins, catalysed by the Ca2+ -dependent enzyme peptidylarginine deiminase 2 (PAD2). Thus, inhibition of PAD2 may be of value in treatment of this disease. Here, we have first characterized the in vitro kinetic properties of the human peptidylarginine deiminase isoform 2 (hPAD2). Phosphatidylserine and phosphatidylcholine reduced its Ca2+ dependence by almost twofold. Second, we have explored the putative inhibitory action of the methyl ester side chain of paclitaxel (TSME), which shares structural features with a synthetic PAD substrate, viz., the benzoyl-L-arginine ethyl ester (BAEE). Using the known crystallographic structure of the homologous enzyme hPAD4 and in silico molecular docking, we have shown that TSME interacted strongly with the catalytic site, albeit with a 100-fold lower affinity than BAEE. Despite paclitaxel having previously been shown to inhibit hPAD2 in vitro, the side chain of paclitaxel alone did not inhibit this enzyme's activity."xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://purl.org/dc/terms/identifier | "doi:10.1139/o08-124"xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://purl.uniprot.org/core/author | "Harauz G."xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://purl.uniprot.org/core/author | "Raijmakers R."xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://purl.uniprot.org/core/author | "Polverini E."xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://purl.uniprot.org/core/author | "Musse A.A."xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://purl.uniprot.org/core/date | "2008"xsd:gYear |
| http://purl.uniprot.org/citations/18923545 | http://purl.uniprot.org/core/name | "Biochem Cell Biol"xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://purl.uniprot.org/core/pages | "437-447"xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://purl.uniprot.org/core/title | "Kinetics of human peptidylarginine deiminase 2 (hPAD2)--reduction of Ca2+ dependence by phospholipids and assessment of proposed inhibition by paclitaxel side chains."xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://purl.uniprot.org/core/volume | "86"xsd:string |
| http://purl.uniprot.org/citations/18923545 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/18923545 |
| http://purl.uniprot.org/citations/18923545 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/18923545 |
| http://purl.uniprot.org/uniprot/#_B4DIU3-mappedCitation-18923545 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18923545 |
| http://purl.uniprot.org/uniprot/#_Q6ZWF8-mappedCitation-18923545 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18923545 |
| http://purl.uniprot.org/uniprot/#_Q9Y2J8-mappedCitation-18923545 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18923545 |
| http://purl.uniprot.org/uniprot/Q6ZWF8 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/18923545 |
| http://purl.uniprot.org/uniprot/Q9Y2J8 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/18923545 |
| http://purl.uniprot.org/uniprot/B4DIU3 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/18923545 |